Clusterin antibody (AA 108-320)
Quick Overview for Clusterin antibody (AA 108-320) (ABIN7599684)
Target
See all Clusterin (CLU) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - AA 108-320
 - 
                                            
Purpose
 - Anti-Clusterin/CLU Antibody Picoband®
 - 
                                            
Cross-Reactivity (Details)
 - No cross-reactivity with other proteins.
 - 
                                            
Characteristics
 - Anti-Clusterin/CLU Antibody Picoband® (ABIN7599684). Tested in ELISA, IHC, WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
 - 
                                            
Purification
 - Immunogen affinity purified.
 - 
                                            
Immunogen
 - E.coli-derived human Clusterin/CLU recombinant protein (Position: A108-Q320).
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - 
                        Western blot, 0.25-0.5 μg/mL, Human
Immunohistochemistry(Paraffin-embedded Section), 2-5 μg/mL, Human
ELISA, 0.1-0.5 μg/mL, -
1. Bertrand, P., Poirier, J., Oda, T., Finch, C. E., Pasinetti, G. M. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Molec. Brain Res. 33: 174-178, 1995. 2. Birkenmeier, E. H., Letts, V. A., Frankel, W. N., Magenheimer, B. S., Calvet, J. P. Sulfated glycoprotein-2 (Sgp-2) maps to mouse chromosome 14. Mammalian Genome 4: 131-132, 1993. Note: Erratum: Mammalian Genome 4: 238 only, 1993. 3. Chen, X., Halberg, R. B., Ehrhardt, W. M., Torrealba, J., Dove, W. F. Clusterin as a biomarker in murine and human intestinal neoplasia. Proc. Nat. Acad. Sci. 100: 9530-9535, 2003. - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Reconstitution
 - Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
 - 
                                            
Concentration
 - 500 μg/mL
 - 
                                            
Buffer
 - Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
 - 
                                            
Storage
 - 4 °C,-20 °C
 - 
                                            
Storage Comment
 - 
                        At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month. 
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing. 
 - 
                                            
 - 
    
- Clusterin (CLU)
 - 
                                            
Alternative Name
 - CLU
 - 
                                            
Background
 - 
                        
Synonyms: Vesicle-fusing ATPase, N-ethylmaleimide-sensitive fusion protein, NEM-sensitive fusion protein, Vesicular-fusion protein NSF, NSF
Background: The protein encoded by this gene is a secreted chaperone that can under some stress conditions also be found in the cell cytosol. It has been suggested to be involved in several basic biological events such as cell death, tumor progression, and neurodegenerative disorders. Alternate splicing results in both coding and non-coding variants.
 - 
                                            
Molecular Weight
 - 70 kDa
 - 
                                            
Gene ID
 - 1191
 - 
                                            
UniProt
 - P10909
 - 
                                            
Pathways
 - Apoptosis, Negative Regulation of intrinsic apoptotic Signaling
 
Target
 -